Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-65.52	-120.42	349.27
Graham Fair Price	525.26	2.68	0.43
PEG	-99.94	0.01	-20.97
Price/Book	-8.92	2.65	2.91
Price/Cash Flow	-37.42	-93.98	150.19
Prices/Earnings	-97.73	-46.95	2064.78
Price/Sales	-0.88	32.25	32.53
Price/FCF	-37.42	-93.98	150.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.07	0.78	0.84
Operating Margin	-113.74	-0.33	-0.15
ROA	3924.70	< 0.005	< 0.005
ROE	< 0.005	-0.01	3905.32
ROIC	< 0.005	-0.01	-599.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-79.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.66	-0.95	64.18
EPS QOQ	-0.98	-40.41	-4004.61
FCF QOQ	-0.61	-2.45	-301.99
Revenue QOQ	-0.20	-0.09	56.82
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	551.97	507.25	-8.10
Days Sales Outstanding (DSO)	72.09	81.78	13.45
Inventory Turnover	0.16	0.18	8.82
Debt/Capitalization	0.29	0.27	-7.98
Quick Ratio	12.65	13.74	8.64
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.81	4.75	-1.20
Cash	5.74	5.56	-3.14
Capex	-0.01	< 0.005	56.80
Free Cash Flow	0.09	-0.13	43.80
Revenue	0.43	0.39	-9.22
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	13.81	15.20	10.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.44	-8.48	-56.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating